Dongjin Jeong

Dongjin Jeong

Auto-generated profile, based on publicly available information

Dongjin Jeong

Laboratory of Immune Regulation, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
YWYeon Duk Woo
Yeon Duk Woo
DJDongjin Jeong
Dongjin Jeong
DCDoo Hyun Chung
Doo Hyun Chung
Yeon Duk Woo, Dongjin Jeong, and Doo Hyun Chung. Mol. Cells 2021;44:292-300. https://doi.org/10.14348/molcells.2021.0058

1 January 2024 in Immune Network
Verified
Journal Article
Open access
PDF file
HKHye Young Kim
Hye Young Kim
DJDongjin Jeong
Dongjin Jeong
JKJi Hyung Kim
Ji Hyung Kim
DCDoo Hyun Chung
Doo Hyun Chung
Kim HY, et al. Immune Netw. 2024 Jan;24(1):e6. https://doi.org/10.4110/in.2024.24.e6

5 July 2021 in eLife
Verified
Journal Article
Open access
DJDongjin Jeong
Dongjin Jeong
HKHye Young Kim
Hye Young Kim
MKMin Jueng Kang
Min Jueng Kang
HJHyeryeon Jung
Hyeryeon Jung
YOYumi Oh
Yumi Oh
DCDoo Hyun Chung
Doo Hyun Chung
To date, no study has demonstrated that soluble Fas ligand (sFasL)-mediated inflammation is regulated via interaction with Fas in vivo. We found that FasL interacts specifically with tumor necrosis factor receptor superfamily (TNFRSF)10B, also known as death receptor (DR)5. Autoantibody-induced arthritis (AIA) was attenuated in FasL (Faslgld/gld)- and soluble FasL (FaslΔs/Δs)-deficient mice, but not in Fas (Faslpr/lprandFas–/–)- or membrane FasL (FaslΔm/Δm)-deficient mice, suggesting sFasL promotes inflammation by binding to a Fas-independent receptor. Affinity purification mass spectrometry analysis using human (h) fibroblast-like synovial cells (FLSCs) identified DR5 as one of several proteins that could be the elusive Fas-independent FasL receptor. Subsequent cellular and biochemical analyses revealed that DR5 interacted specifically with recombinant FasL–Fc protein, although the strength of this interaction was approximately 60-fold lower than the affinity between TRAIL and DR5. A microarray assay using joint tissues from mice with arthritis implied that the chemokine CX3CL1 may play an important downstream role of the interaction. The interaction enhancedCx3cl1transcription and increased sCX3CL1 production in FLSCs, possibly in an NF-κB-dependent manner. Moreover, the sFasL–DR5 interaction-mediated CX3CL1–CX3CR1 axis initiated and amplified inflammation by enhancing inflammatory cell influx and aggravating inflammation via secondary chemokine production. Blockade of FasL or CX3CR1 attenuated AIA. Therefore, the sFasL–DR5 interaction promotes inflammation and is a potential therapeutic target.

1 September 2017 in Transaction of the Korean Society of Automotive Engineers
Verified
Journal Article
Closed access
IBInsun Baek
Insun Baek
JAJeonghoon An
Jeonghoon An
DJDongjin Jeong
Dongjin Jeong
DJDogeun Jung
Dogeun Jung